-
Security Type
-
Crowd SAFE
-
Min Investment
-
$100
-
Location
-
SAN FRANCISCO, CA
-
Offering Date
-
May 08, 2023
-
Expected Close Date
-
August 07, 2023
-
Target Raise
-
$25.00K-$1.24M
-
No. Investors
-
251
-
Security Price
-
$1
- Number of Employees
- 2
- Cash
- $324,314
- Revenue
- $247,786
- Short Term Debt
- $52,668
- Cost of Goods
- $49,972
- Long Term Debt
- $0
- Net Income
- $-406,203
Company Description
According to "Giving USA," over $40 billion is donated annually to health-related causes, however, investing in healthcare innovation continues to be difficult.
Perks
Invest
$500
Receive
Bioverge digital social media badge
Bioverge laptop sticker
6 investors
Invest
$2,500
Receive
All previous perks
Limited edition, custom designed Bioverge t-shirt
Limited edition, custom designed Bioverge hat
Limited (494 left of 500)
Invest
$5,000
Receive
All previous perks
Meet and Greet video call with the founders
Invest
$10,000
Receive
All previous perks
VIP seat at our next annual event
Invest
$25,000
Receive
All previous perks
25% reduction in carry on your first 3 Bioverge investments
Invest
$50,000
Receive
All previous perks
25% reduction in carry for all future Bioverge investments
Key Deal Facts
Democratizing investing in curated healthcare + technology startups
$3B+ value of portfolio companies (Q4 2022) | 40.5% AUM growth (2021-2022)
Portfolio of 37 companies | 24.7% realized net IRR*, 2.3x realized MOIC*
Raised $8M+ across 61 deals and 4 multi-company Access Funds
Co-invested with top VC firms: Andreessen Horowitz, Khosla, Sequoia...
Leveraging artificial intelligence-driven diligence process for investments
Republic investors instantly become part of our diversified portfolio
Management Team / Advisory Board Bios
Neil Littman
Co-founder & CEO
I am the Founder & CEO of Bioverge, we fuse sci-fi with fintech through a bio + tech investment platform.
Rick Gibb
Co-founder & COO
Investing in the future of healthcare
@Bioverge. Formerly @Stanford
Janine McCargo
Media & PR
Luiz Ferreira
Engineer & Software Development
Hollis Fullilove
Finance & Accouting
Curt Herberts
Advisor
Greg Simon
Advisor
Sonia Arrison
Advisor
Mark Chao
Advisor
Brenden Boot
Advisor
Brock Reeve
Advisor
Joseph Wu
Advisor
Dave Chisholm
Advisor
Kevin Coker
Advisor
David Stubbs
Advisor
Rishav Dasgupta
Analyst